Hims’ Super Bowl fallout, and the FDA reverses course
STAT's Readout LOUD covers Hims' Super Bowl GLP-1 ad and regulatory fallout, the FDA reversing course to review Moderna's influenza vaccine application, and discussion of Compass Pathways' psychedelic depression data and implications for approval standards.
Why it mattersFDA's decision to review Moderna's flu vaccine signals regulators may change timelines, requiring submission strategy updates.